Bioinformatics Advance Access originally published online on September 25, 2006
Bioinformatics 2006 22(22):2761-2767; doi:10.1093/bioinformatics/btl479
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Peptide length-based prediction of peptideMHC class II binding
1 Program in Bioinformatics, University of Michigan Ann Arbor, MI, USA
2 Department of Biostatistics, University of Michigan Ann Arbor, MI, USA
3 Department of Microbiology and Immunology, University of Michigan Ann Arbor, MI, USA
4 Department of Chemical Engineering, University of Michigan Ann Arbor, MI, USA
5 Department of Biomedical Engineering, University of Michigan Ann Arbor, MI, USA
*To whom correspondence should be addressed.
Motivation: Algorithms for predicting peptideMHC class II binding are typically similar, if not identical, to methods for predicting peptideMHC class I binding despite known differences between the two scenarios. We investigate whether representing one of these differences, the greater range of peptide lengths binding MHC class II, improves the performance of these algorithms.
Results: A non-linear relationship between peptide length and peptideMHC class II binding affinity was identified in the data available for several MHC class II alleles. Peptide length was incorporated into existing prediction algorithms using one of several modifications: using regression to pre-process the data, using peptide length as an additional variable within the algorithm, or representing register shifting in longer peptides. For several datasets and at least two algorithms these modifications consistently improved prediction accuracy.
Availability: http://malthus.micro.med.umich.edu/Bioinformatics
Contact: linderma{at}umich.edu
Received on April 14, 2006; revised on September 7, 2006; accepted on September 8, 2006
This article has been cited by other articles:
![]() |
P. J. Hanley, C. R. Y. Cruz, B. Savoldo, A. M. Leen, M. Stanojevic, M. Khalil, W. Decker, J. J. Molldrem, H. Liu, A. P. Gee, et al. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes Blood, August 27, 2009; 114(9): 1958 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lundegaard, O. Lund, C. Kesmir, S. Brunak, and M. Nielsen Modeling the adaptive immune system: predictions and simulations Bioinformatics, December 15, 2007; 23(24): 3265 - 3275. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bollard, S. Gottschalk, A. M. Leen, H. Weiss, K. C. Straathof, G. Carrum, M. Khalil, M.-f. Wu, M. H. Huls, C.-C. Chang, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer Blood, October 15, 2007; 110(8): 2838 - 2845. [Abstract] [Full Text] [PDF] |
||||

